Ho sostenuto un colloquio presso Takeda Pharmaceuticals
Colloquio
The phone screening with hr first and then with the hiring manager. The final interview is on-site with the whole team. The seminar is optional and depends on your application title.
Domande di colloquio [1]
Domanda 1
Specific skills checklist and personality questions
Ho sostenuto un colloquio presso Takeda Pharmaceuticals (Boston, MA)
Colloquio
Good thing about the interview process was that the PM was actively hiring, therefore I got to the final stage in a relative short time. However, I found rudeness in the post-interview treatment, being myself the one that reached out several times to learn they would not proceed with the offer. Interview process for my role was intensive, going from 1:1 conversation with different people to a whole team oral presentation, lasting a total of 6 h. The only feedback I got is that they expected more details in my oral presentation about how I performed my routine work... IMO, that would have not been ethically correct with the NDA I had with my former company.
Domande di colloquio [1]
Domanda 1
The questions were technical for my job description: procedures, experience in cell culture, experience in mAbs production and protein purification. They would reinforce all the negative statements instead of being curious about other capabilities or how could I compensate the lack of experience (not knowledge, that is important to stress). The rest of the 1:1 interviews, I kept answering the same questions all over again (guess they tested coherence?), but I felt they were not really wanting to know me. I guess it depends on the team dynamics.
Ho presentato la mia candidatura online. La procedura ha richiesto 2 settimane. Ho sostenuto un colloquio presso Takeda Pharmaceuticals (Cambridge, MA) nel mese di set 2024
Colloquio
Interview has a screening phone call with recruiter followed by a 30 min zoom meeting with hiring manager. Then in person interview started with a 40 min seminar + 20 min Q&A, followed by several 1-on-1 interviews with various stakeholders.
